Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-15-003828
Filing Date
2015-05-11
Accepted
2015-05-11 16:15:46
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2015 n5115310q.htm 10-Q 858862
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 16569
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 16965
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6710
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6649
  Complete submission text file 0001214659-15-003828.txt   4352694

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS anth-20150331.xml EX-101.INS 382064
7 EXHIBIT 101.SCH anth-20150331.xsd EX-101.SCH 36807
8 EXHIBIT 101.CAL anth-20150331_cal.xml EX-101.CAL 32134
9 EXHIBIT 101.DEF anth-20150331_def.xml EX-101.DEF 124173
10 EXHIBIT 101.LAB anth-20150331_lab.xml EX-101.LAB 714293
11 EXHIBIT 101.PRE anth-20150331_pre.xml EX-101.PRE 255253
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 15850919
SIC: 2834 Pharmaceutical Preparations